nivolumab,ipilimumab
bms
['biomarker']
 bingo! the power is in the biomarker. the response is very exciting, but predicted. let s think of other attractive alternatives that could likely generate the same response for these tumors and could be more applicable across global world 
Tumor Immunology, TME, Systemic Immunity, Radiation Oncology, University of Colorado